ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

CIT CIT Group Inc

53.50
0.00 (0.00%)
Pre Market
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
CIT Group Inc NYSE:CIT NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 53.50 0 01:00:00

CIT Provides $20 Million Credit Facility for Protech Home Medical

21/09/2020 1:00pm

PR Newswire (US)


CIT (NYSE:CIT)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more CIT Charts.

NEW YORK, Sept. 21, 2020 /PRNewswire/ -- CIT Group Inc. (NYSE: CIT) today announced that its Healthcare Finance group, part of the company's Commercial Finance division, provided a $20 million senior secured credit facility for Protech Home Medical Corp. (TSXV: PTQ) (OTCQX: PTQQF), a leader in the home medical equipment industry focused on end-to-end respiratory care.

(PRNewsfoto/CIT Group Inc.)

Based in Cincinnati, Ohio, Protech Home Medical provides clients with a broad range of in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States healthcare market. The credit facility will be used for general corporate purposes, acquisitions and ongoing business development.

"This senior credit facility with CIT is truly a momentous moment for Protech and I could not be prouder of the entire team for their continued hard work that led us to this very significant moment. With this new credit facility in place, we have added another tool in our toolbox that will further enable us to take the company through its next stage of growth with our key objectives in mind," Greg Crawford, chairman and CEO of Protech.

"Protech Home Medical is recognized as a leader in the home medical equipment industry, particularly with regard to respiratory care," said William Douglass, managing director and group head for CIT's Healthcare Finance business. "We were pleased to arrange the financing to support their continued operations and ongoing business development objectives."

In connection with the financing, CIT is also providing a package of treasury management and capital markets services.

CIT's Healthcare Finance unit, part of its Commercial Finance division, provides comprehensive financing and banking solutions to middle market healthcare companies across the U.S. By using a client-focused and industry-centric model, the Healthcare Finance team can tailor its products and services to help clients meet their needs for growth capital.

About CIT
CIT is a leading national bank focused on empowering businesses and personal savers with the financial agility to navigate their goals. CIT Group Inc. (NYSE: CIT) is a financial holding company with over a century of experience and operates a principal bank subsidiary, CIT Bank, N.A. (Member FDIC, Equal Housing Lender). The company's commercial banking segment includes commercial financing, community association banking, middle market banking, equipment and vendor financing, factoring, railcar financing, treasury and payments services, and capital markets and asset management. CIT's consumer banking segment includes a national direct bank and regional branch network. Discover more at cit.com/about.

About Protech Home Medical Corp.
The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility and other chronic health conditions. The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company's organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient's services and making life easier for the patient.

MEDIA RELATIONS: 
John M. Moran
212-461-5507
john.moran@cit.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/cit-provides-20-million-credit-facility-for-protech-home-medical-301134334.html

SOURCE CIT Group Inc.

Copyright 2020 PR Newswire

1 Year CIT Chart

1 Year CIT Chart

1 Month CIT Chart

1 Month CIT Chart

Your Recent History

Delayed Upgrade Clock